Global Human Immune Globulin Intravenous Market Research Report 2025(Status and Outlook)

March 2025 | 224 pages | ID: G7AD8349E3B0EN
Bosson Research

Abstracts

Report Overview

Immune globulin (Ig) short-term protection against hepatitis A and measles

This report provides a deep insight into the global Immune Globulin Intravenous market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Globulin Intravenous Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Globulin Intravenous market in any manner.

Global Immune Globulin Intravenous Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Takeda

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Market Segmentation (by Type)

IVIg Liquid

IVIg Powder

Market Segmentation (by Application)

Immunodeficiency

Autoimmune Disease

Acute Infection

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immune Globulin Intravenous Market
• Overview of the regional outlook of the Immune Globulin Intravenous Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Globulin Intravenous Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Immune Globulin Intravenous
1.2 Key Market Segments
1.2.1 Human Immune Globulin Intravenous Segment by Type
1.2.2 Human Immune Globulin Intravenous Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Human Immune Globulin Intravenous Market Overview
2.1 Global Market Overview
2.1.1 Global Human Immune Globulin Intravenous Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Human Immune Globulin Intravenous Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Human Immune Globulin Intravenous Product Life Cycle
3.3 Global Human Immune Globulin Intravenous Sales by Manufacturers (2020-2025)
3.4 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Human Immune Globulin Intravenous Manufacturing Sites, Area Served, Product Type
3.8 Human Immune Globulin Intravenous Market Competitive Situation and Trends
3.8.1 Human Immune Globulin Intravenous Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Immune Globulin Intravenous Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Human Immune Globulin Intravenous Industry Chain Analysis
4.1 Human Immune Globulin Intravenous Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Immune Globulin Intravenous Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Immune Globulin Intravenous Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Human Immune Globulin Intravenous Market
5.7 ESG Ratings of Leading Companies
6 Global Human Immune Globulin Intravenous Market by Region
6.1 Global Human Immune Globulin Intravenous Market Size by Region
6.1.1 Global Human Immune Globulin Intravenous Market Size by Region
6.1.2 Global Human Immune Globulin Intravenous Market Size Market Share by Region
6.2 Global Human Immune Globulin Intravenous Sales by Region
6.2.1 Global Human Immune Globulin Intravenous Sales by Region
6.2.2 Global Human Immune Globulin Intravenous Sales Market Share by Region
7 North America Market Overview
7.1 North America Human Immune Globulin Intravenous Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Human Immune Globulin Intravenous Market Size by Type
7.3 North America Human Immune Globulin Intravenous Market Size by Application
8 Europe Market Overview
8.1 Europe Human Immune Globulin Intravenous Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Human Immune Globulin Intravenous Market Size by Type
8.3 Europe Human Immune Globulin Intravenous Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Human Immune Globulin Intravenous Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Human Immune Globulin Intravenous Market Size by Type
9.3 Asia-Pacific Human Immune Globulin Intravenous Market Size by Application
10 South America Market Overview
10.1 South America Human Immune Globulin Intravenous Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Human Immune Globulin Intravenous Market Size by Type
10.3 South America Human Immune Globulin Intravenous Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Human Immune Globulin Intravenous Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Human Immune Globulin Intravenous Market Size by Type
11.3 Middle East and Africa Human Immune Globulin Intravenous Market Size by Application
12 Human Immune Globulin Intravenous Market Production by Region
12.1 Global Production of Human Immune Globulin Intravenous by Region(2020-2025)
12.2 Global Human Immune Globulin Intravenous Revenue Market Share by Region (2020-2025)
12.3 Global Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Human Immune Globulin Intravenous Production
12.4.1 North America Human Immune Globulin Intravenous Production Growth Rate (2020-2025)
12.4.2 North America Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Human Immune Globulin Intravenous Production
12.5.1 Europe Human Immune Globulin Intravenous Production Growth Rate (2020-2025)
12.5.2 Europe Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Human Immune Globulin Intravenous Production (2020-2025)
12.6.1 Japan Human Immune Globulin Intravenous Production Growth Rate (2020-2025)
12.6.2 Japan Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Human Immune Globulin Intravenous Production (2020-2025)
12.7.1 China Human Immune Globulin Intravenous Production Growth Rate (2020-2025)
12.7.2 China Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2020-2025)
13 Human Immune Globulin Intravenous Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Human Immune Globulin Intravenous Sales Market Share by Type (2020-2033)
13.3 Global Human Immune Globulin Intravenous Market Size Market Share by Type (2020-2033)
13.4 Global Human Immune Globulin Intravenous Price by Type (2020-2033)
14 Human Immune Globulin Intravenous Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Human Immune Globulin Intravenous Market Sales by Application (2020-2033)
14.3 Global Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2033)
14.4 Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Takeda
15.1.1 Takeda Basic Information
15.1.2 Takeda Human Immune Globulin Intravenous Product Overview
15.1.3 Takeda Human Immune Globulin Intravenous Product Market Performance
15.1.4 Takeda Business Overview
15.1.5 Takeda SWOT Analysis
15.1.6 Takeda Recent Developments
15.2 Grifols
15.2.1 Grifols Basic Information
15.2.2 Grifols Human Immune Globulin Intravenous Product Overview
15.2.3 Grifols Human Immune Globulin Intravenous Product Market Performance
15.2.4 Grifols Business Overview
15.2.5 Grifols SWOT Analysis
15.2.6 Grifols Recent Developments
15.3 CSL
15.3.1 CSL Basic Information
15.3.2 CSL Human Immune Globulin Intravenous Product Overview
15.3.3 CSL Human Immune Globulin Intravenous Product Market Performance
15.3.4 CSL Business Overview
15.3.5 CSL SWOT Analysis
15.3.6 CSL Recent Developments
15.4 Octapharma
15.4.1 Octapharma Basic Information
15.4.2 Octapharma Human Immune Globulin Intravenous Product Overview
15.4.3 Octapharma Human Immune Globulin Intravenous Product Market Performance
15.4.4 Octapharma Business Overview
15.4.5 Octapharma Recent Developments
15.5 Biotest
15.5.1 Biotest Basic Information
15.5.2 Biotest Human Immune Globulin Intravenous Product Overview
15.5.3 Biotest Human Immune Globulin Intravenous Product Market Performance
15.5.4 Biotest Business Overview
15.5.5 Biotest Recent Developments
15.6 Kedrion
15.6.1 Kedrion Basic Information
15.6.2 Kedrion Human Immune Globulin Intravenous Product Overview
15.6.3 Kedrion Human Immune Globulin Intravenous Product Market Performance
15.6.4 Kedrion Business Overview
15.6.5 Kedrion Recent Developments
15.7 Hualan Bio
15.7.1 Hualan Bio Basic Information
15.7.2 Hualan Bio Human Immune Globulin Intravenous Product Overview
15.7.3 Hualan Bio Human Immune Globulin Intravenous Product Market Performance
15.7.4 Hualan Bio Business Overview
15.7.5 Hualan Bio Recent Developments
15.8 CNBG
15.8.1 CNBG Basic Information
15.8.2 CNBG Human Immune Globulin Intravenous Product Overview
15.8.3 CNBG Human Immune Globulin Intravenous Product Market Performance
15.8.4 CNBG Business Overview
15.8.5 CNBG Recent Developments
15.9 Shanghai RAAS
15.9.1 Shanghai RAAS Basic Information
15.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Overview
15.9.3 Shanghai RAAS Human Immune Globulin Intravenous Product Market Performance
15.9.4 Shanghai RAAS Business Overview
15.9.5 Shanghai RAAS Recent Developments
15.10 CBPO
15.10.1 CBPO Basic Information
15.10.2 CBPO Human Immune Globulin Intravenous Product Overview
15.10.3 CBPO Human Immune Globulin Intravenous Product Market Performance
15.10.4 CBPO Business Overview
15.10.5 CBPO Recent Developments
15.11 LFB Group
15.11.1 LFB Group Basic Information
15.11.2 LFB Group Human Immune Globulin Intravenous Product Overview
15.11.3 LFB Group Human Immune Globulin Intravenous Product Market Performance
15.11.4 LFB Group Business Overview
15.11.5 LFB Group Recent Developments
15.12 BPL
15.12.1 BPL Basic Information
15.12.2 BPL Human Immune Globulin Intravenous Product Overview
15.12.3 BPL Human Immune Globulin Intravenous Product Market Performance
15.12.4 BPL Business Overview
15.12.5 BPL Recent Developments
15.13 Sichuan Yuanda Shuyang
15.13.1 Sichuan Yuanda Shuyang Basic Information
15.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
15.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Market Performance
15.13.4 Sichuan Yuanda Shuyang Business Overview
15.13.5 Sichuan Yuanda Shuyang Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 4. Global Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 5. Human Immune Globulin Intravenous Market Size Comparison by Region (M USD)
Table 6. Global Human Immune Globulin Intravenous Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Immune Globulin Intravenous Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2024)
Table 11. Global Market Human Immune Globulin Intravenous Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Human Immune Globulin Intravenous Manufacturing Sites and Area Served
Table 13. Manufacturers Human Immune Globulin Intravenous Product Type
Table 14. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Immune Globulin Intravenous Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Human Immune Globulin Intravenous Market Size Comparison by Region (M USD)
Table 26. Global Human Immune Globulin Intravenous Market Size by Region (2020-2033) & (M USD)
Table 27. Global Human Immune Globulin Intravenous Market Size Market Share by Region (2020-2033)
Table 28. Global Human Immune Globulin Intravenous Sales by Region (2020-2033) & (K MT)
Table 29. Global Human Immune Globulin Intravenous Sales Market Share by Region (2020-2033)
Table 30. North America Human Immune Globulin Intravenous Market Size by Country (2020-2033) & (M USD)
Table 31. North America Human Immune Globulin Intravenous Sales by Country (2020-2033) & (K MT)
Table 32. North America Human Immune Globulin Intravenous Sales by Type (K MT)
Table 33. North America Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 34. North America Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 35. North America Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2033)
Table 36. North America Human Immune Globulin Intravenous Sales by Application (K MT)
Table 37. North America Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 38. North America Human Immune Globulin Intravenous Sales (K MT) by Application (2020-2033)
Table 39. North America Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2033)
Table 40. Europe Human Immune Globulin Intravenous Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Human Immune Globulin Intravenous Sales by Country (2020-2033) & (K MT)
Table 42. Europe Human Immune Globulin Intravenous Sales by Type (K MT)
Table 43. Europe Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 44. Europe Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 45. Europe Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2033)
Table 46. Europe Human Immune Globulin Intravenous Sales by Application (K MT)
Table 47. Europe Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 48. Europe Human Immune Globulin Intravenous Sales (K MT) by Application (2020-2033)
Table 49. Europe Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Human Immune Globulin Intravenous Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Human Immune Globulin Intravenous Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Human Immune Globulin Intravenous Sales by Type (K MT)
Table 53. Asia-Pacific Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 54. Asia-Pacific Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Human Immune Globulin Intravenous Sales by Application (K MT)
Table 57. Asia-Pacific Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 58. Asia-Pacific Human Immune Globulin Intravenous Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2025)
Table 60. South America Human Immune Globulin Intravenous Market Size by Country (2020-2033) & (M USD)
Table 61. South America Human Immune Globulin Intravenous Sales by Country (2020-2033) & (K MT)
Table 62. South America Human Immune Globulin Intravenous Sales by Type (K MT)
Table 63. South America Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 64. South America Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 65. South America Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2033)
Table 66. South America Human Immune Globulin Intravenous Sales by Application (K MT)
Table 67. South America Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 68. South America Human Immune Globulin Intravenous Sales (K MT) by Application (2020-2033)
Table 69. South America Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Human Immune Globulin Intravenous Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Human Immune Globulin Intravenous Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Human Immune Globulin Intravenous Sales by Type (K MT)
Table 73. Middle East and Africa Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 74. Middle East and Africa Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Human Immune Globulin Intravenous Sales by Application (K MT)
Table 77. Middle East and Africa Human Immune Globulin Intravenous Market Size by Application (M USD)
Table 78. Middle East and Africa Human Immune Globulin Intravenous Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Human Immune Globulin Intravenous Market Size (M USD) by Application (2020-2033)
Table 80. Global Human Immune Globulin Intravenous Production (K MT) by Region(2020-2025)
Table 81. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2020-2025)
Table 83. Global Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Human Immune Globulin Intravenous Sales by Type (K MT)
Table 89. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 90. Global Human Immune Globulin Intravenous Sales (K MT) by Type (2020-2033)
Table 91. Global Human Immune Globulin Intravenous Sales Market Share by Type (2020-2033)
Table 92. Global Human Immune Globulin Intravenous Market Size (M USD) by Type (2020-2033)
Table 93. Global Human Immune Globulin Intravenous Market Size Share by Type (2020-2033)
Table 94. Global Human Immune Globulin Intravenous Sales (K MT) by Application
Table 95. Global Human Immune Globulin Intravenous Market Size by Application(M USD)
Table 96. Global Human Immune Globulin Intravenous Sales by Application (2020-2033) & (K MT)
Table 97. Global Human Immune Globulin Intravenous Sales Market Share by Application (2020-2033)
Table 98. Global Human Immune Globulin Intravenous Market Size by Application (2020-2033) & (M USD)
Table 99. Global Human Immune Globulin Intravenous Market Share by Application (2020-2033)
Table 100. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2020-2033)
Table 101. Takeda Basic Information
Table 102. Takeda Human Immune Globulin Intravenous Product Overview
Table 103. Takeda Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Takeda Business Overview
Table 105. Takeda SWOT Analysis
Table 106. Takeda Recent Developments
Table 107. Grifols Basic Information
Table 108. Grifols Human Immune Globulin Intravenous Product Overview
Table 109. Grifols Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Grifols Business Overview
Table 111. Grifols SWOT Analysis
Table 112. Grifols Recent Developments
Table 113. CSL Basic Information
Table 114. CSL Human Immune Globulin Intravenous Product Overview
Table 115. CSL Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. CSL Business Overview
Table 117. CSL SWOT Analysis
Table 118. CSL Recent Developments
Table 119. Octapharma Basic Information
Table 120. Octapharma Human Immune Globulin Intravenous Product Overview
Table 121. Octapharma Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Octapharma Business Overview
Table 123. Octapharma Recent Developments
Table 124. Biotest Basic Information
Table 125. Biotest Human Immune Globulin Intravenous Product Overview
Table 126. Biotest Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biotest Business Overview
Table 128. Biotest Recent Developments
Table 129. Kedrion Basic Information
Table 130. Kedrion Human Immune Globulin Intravenous Product Overview
Table 131. Kedrion Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Kedrion Business Overview
Table 133. Kedrion Recent Developments
Table 134. Hualan Bio Basic Information
Table 135. Hualan Bio Human Immune Globulin Intravenous Product Overview
Table 136. Hualan Bio Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Hualan Bio Business Overview
Table 138. Hualan Bio Recent Developments
Table 139. CNBG Basic Information
Table 140. CNBG Human Immune Globulin Intravenous Product Overview
Table 141. CNBG Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. CNBG Business Overview
Table 143. CNBG Recent Developments
Table 144. Shanghai RAAS Basic Information
Table 145. Shanghai RAAS Human Immune Globulin Intravenous Product Overview
Table 146. Shanghai RAAS Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Shanghai RAAS Business Overview
Table 148. Shanghai RAAS Recent Developments
Table 149. CBPO Basic Information
Table 150. CBPO Human Immune Globulin Intravenous Product Overview
Table 151. CBPO Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. CBPO Business Overview
Table 153. CBPO Recent Developments
Table 154. LFB Group Basic Information
Table 155. LFB Group Human Immune Globulin Intravenous Product Overview
Table 156. LFB Group Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. LFB Group Business Overview
Table 158. LFB Group Recent Developments
Table 159. BPL Basic Information
Table 160. BPL Human Immune Globulin Intravenous Product Overview
Table 161. BPL Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. BPL Business Overview
Table 163. BPL Recent Developments
Table 164. Sichuan Yuanda Shuyang Basic Information
Table 165. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
Table 166. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Sichuan Yuanda Shuyang Business Overview
Table 168. Sichuan Yuanda Shuyang Recent Developments
List of Figures
Figure 1. Product Picture of Human Immune Globulin Intravenous
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Immune Globulin Intravenous Market Size (M USD), 2024-2033
Figure 5. Global Human Immune Globulin Intravenous Market Size (M USD) (2020-2033)
Figure 6. Global Human Immune Globulin Intravenous Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Immune Globulin Intravenous Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Immune Globulin Intravenous Product Life Cycle
Figure 13. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2024
Figure 14. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2024
Figure 15. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Immune Globulin Intravenous Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Immune Globulin Intravenous Revenue in 2024
Figure 18. Industry Chain Map of Human Immune Globulin Intravenous
Figure 19. Global Human Immune Globulin Intravenous Market PEST Analysis
Figure 20. Global Human Immune Globulin Intravenous Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Human Immune Globulin Intravenous Market Size by Region
Figure 27. Global Human Immune Globulin Intravenous Market Size Market Share by Region (2020-2033)
Figure 28. Global Human Immune Globulin Intravenous Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Human Immune Globulin Intravenous Market Size (M USD) by Country
Figure 33. USA Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Human Immune Globulin Intravenous Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Human Immune Globulin Intravenous Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Human Immune Globulin Intravenous Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Human Immune Globulin Intravenous Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Human Immune Globulin Intravenous Market Size (M USD)by Type
Figure 40. North America Human Immune Globulin Intravenous Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Human Immune Globulin Intravenous Market Size (M USD) by Country
Figure 45. Germany Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Human Immune Globulin Intravenous Market Size (M USD) by Type
Figure 56. Europe Human Immune Globulin Intravenous Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Human Immune Globulin Intravenous Market Size (M USD) by Country
Figure 61. China Human Immune Globulin Intravenous Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Human Immune Globulin Intravenous Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Human Immune Globulin Intravenous Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Human Immune Globulin Intravenous Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Human Immune Globulin Intravenous Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Human Immune Globulin Intravenous Market Size (M USD) by Type
Figure 72. Asia-Pacific Human Immune Globulin Intravenous Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Human Immune Globulin Intravenous Market Size (M USD) by Country
Figure 77. Brazil Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Human Immune Globulin Intravenous Market Size (M USD) by Type
Figure 84. South America Human Immune Globulin Intravenous Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Human Immune Globulin Intravenous Market Size (M USD) by Country
Figure 89. Saudi Arabia Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Human Immune Globulin Intravenous Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Human Immune Globulin Intravenous Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Human Immune Globulin Intravenous Market Size (M USD) by Type
Figure 100. Middle East and Africa Human Immune Globulin Intravenous Market Size (M USD) by Application
Figure 101. Global Human Immune Globulin Intravenous Production Market Share by Region (2020-2025)
Figure 102. North America Human Immune Globulin Intravenous Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Human Immune Globulin Intravenous Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Human Immune Globulin Intravenous Production (K MT) Growth Rate (2020-2025)
Figure 105. China Human Immune Globulin Intravenous Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Figure 108. Sales Market Share of Human Immune Globulin Intravenous by Type (2020-2033)
Figure 109. Sales Market Share of Human Immune Globulin Intravenous by Type in 2024
Figure 110. Market Size Share of Human Immune Globulin Intravenous by Type (2020-2033)
Figure 111. Market Size Share of Human Immune Globulin Intravenous by Type in 2024
Figure 112. Global Human Immune Globulin Intravenous Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Human Immune Globulin Intravenous Market Size by Application(M USD)
Figure 115. Global Human Immune Globulin Intravenous Market Share by Application
Figure 116. Global Human Immune Globulin Intravenous Sales Market Share by Application (2020-2033)
Figure 117. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2024
Figure 118. Global Human Immune Globulin Intravenous Market Share by Application (2020-2033)
Figure 119. Global Human Immune Globulin Intravenous Market Share by Application in 2024
Figure 120. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2020-2033)